Abstract:[Objective] To investigate the safety and efficacy of a novel intervertebral bone grafting technique with a self-developed de- vice by comparison with the conventional technique in transforaminal lumbar interbody fusion (TLIF) for lumbar degenerative diseases. [Methods] A retrospective study was conducted on 119 patients who received TLIF for lumbar degenerative diseases from September 2018 to August 2019. According to doctor-patient communication, 61 patients had TLIF performed with the novel intervertebral bone grafting by a self-developed device (the NIBG group) , while the other 58 patients were with traditional intervertebral bone grafting (the TIBG group) . The perioperative, follow-up and imaging data were compared between the two groups. [Results] All patients in both groups had surgical procedures conducted successfully with no iatrogenic injuries to nerve roots or dura sac. The NIBG group had significantly less time spend for intervertebral bone grafting than the TIBG group (P<0.05) , although there were no significant differences in operative time, intraopera- tive blood loss, postoperative drainage and postoperative walking time between the two groups (P>0.05) . In addition, there was no signifi- cant difference in the time to resume full weight-bearing activity between the two groups (P>0.05) . As time went during follow-up lasted for (22.94±2.28) months, the VAS and ODI scores decreased significantly (P<0.05) , while JOA score increased significantly in both groups (P<0.05) . At any corresponding time points, there was no a significant difference in the above items between the two groups (P>0.05) . Ra- diographically, intervertebral height, local Cobb angle, and L2~S1 lordosis angle significantly increased in both groups at 1 month postopera- tively and the latest follow-up compared with those preoperatively (P<0.05) . The Lenke scale for interbody fusion improved significantly over time in both groups (P<0.05) , which in the NIBG group proved significantly superior to the TIBG group at 3 months postoperatively, whereas became not statistically significant between the two groups at 6 months and the latest follow-up (P>0.05) . [Conclusion] This novel intervertebral bone grafting technique with the self-developed device does improve the safety, efficacy and interbody fusion of TLIF.